OncoTherapy Science
4564.TTSE GROWTHPharmaceutical
Major holders (5%+) · 1
| Holder | Stake |
|---|---|
| Yusuke Nakamura | 6.05% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 1
| Long Corridor Asset Management Limited | 4.63% |
Ownership history · 51
| Holder | Ratio | Change |
|---|---|---|
| Long Corridor Asset Management Limited2025-12-12 · amended | 18.81% | no change |
| Long Corridor Asset Management Limited2025-12-10 | 18.81% | +14.80pp |
| Long Corridor Asset Management Limited2025-10-01 · amended | 4.01% | no change |
| Long Corridor Asset Management Limited2025-10-01 · amended | 4.01% | no change |
| Long Corridor Asset Management Limited2025-10-01 · amended | 4.01% | -1.36pp |
| Long Corridor Asset Management Limited2025-09-30 | 5.37% | -1.42pp |
| Long Corridor Asset Management Limited2025-09-25 | 6.79% | -1.48pp |
| Long Corridor Asset Management Limited2025-09-08 | 8.27% | -0.88pp |
| Long Corridor Asset Management Limited2025-09-01 | 9.15% | -0.89pp |
| Long Corridor Asset Management Limited2025-08-18 | 10.04% | -1.47pp |
| Long Corridor Asset Management Limited2025-07-01 | 11.51% | -3.68pp |
| Long Corridor Asset Management Limited2025-06-30 | 15.19% | -0.29pp |
| Long Corridor Asset Management Limited2025-06-27 | 15.48% | -1.50pp |
| Long Corridor Asset Management Limited2025-06-23 | 16.98% | -0.15pp |
| Long Corridor Asset Management Limited2025-06-17 | 17.13% | -1.33pp |
| Long Corridor Asset Management Limited2025-05-30 | 18.46% | -1.03pp |
| Long Corridor Asset Management Limited2025-05-07 | 19.49% | +15.51pp |
| Long Corridor Asset Management Limited2024-07-16 | 3.98% | -2.10pp |
| Long Corridor Asset Management Limited2024-07-05 | 6.08% | -0.10pp |
| Long Corridor Asset Management Limited2024-07-02 | 6.18% | -2.28pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.